Investor mix
8 investors on record; lead investors include CureDuchenne.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 63% |
| Angel & family office | 1 | 13% |
| Other / undisclosed | 2 | 25% |
Developer of therapies for treating bone disorders
8 investors on record; lead investors include CureDuchenne.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 63% |
| Angel & family office | 1 | 13% |
| Other / undisclosed | 2 | 25% |